Approvals/CIMA-AEMPS/DEFERASIROX ABDI 360 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Approved

STANDARD

DEFERASIROX ABDI 360 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Abdi Farma Gmbh🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 21f2f675fe9d9acd
Drug Cima Aemps Name: DEFERASIROX ABDI 360 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number: 87277
Holder Company Name: Abdi Farma Gmbh
Marketing Company Name: Xentenel Pharma Europe S.L.
Authorization Date: 2022-07-21
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 360 mg
Route Of Administration: VÍA ORAL
Prescription Type: Diagnóstico Hospitalario
Commercialized: Yes
Company Name: Abdi Farma Gmbh

DEFERASIROX

360 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jul 21, 2022

Approval ID

21f2f675fe9d9acd

Type

Standard